Close Menu

NEW YORK (GenomeWeb) – Circulomics today announced a $1.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences to create nucleic acid extraction products based on its Nanobind technology.

The firm said in a statement that it would use the grant to develop Nanobind technologies for automated and microvolume clinical sample preparation. It is building a pipeline of chemistries to extract DNA and RNA from sample types including cultured cells, blood, and other fluids, and from pathogens.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.